Global Regulators Confirm No Link Between Paracetamol U…
Between September 23–26, 2025, multiple health authorities, including Singapore’s Health Sciences Authority (HSA), Australia’s Therape…
Read more
Regulatory Update on ISO Targets 1,4-Dioxane in Cosmeti…
On 7 August 2025, the International Organization for Standardization (ISO) announced the registration of a new project, ISO/AWI 24913, d…
Read more
Indonesia BPOM Revises Drug Registration Rules to Strea…
Published on August 19, 2025, by the Indonesian National Agency of Drug and Food Control (BPOM), Regulation No. 23 of 2025 introduces major…
Read more
$7 Billion Parkinson’s Disease Market by 2033: Implic…
On August 5, 2025, Clinical Trials Arena released a market forecast detailing significant growth in Parkinson’s disease (PD) therapeutics …
Read more
Drug Shortages Threaten Patient Safety in Africa
The U.S. Agency for International Development (USAID) is responsible for nearly 70% of American global health aid [9]. As a result, recent p…
Read more
The Future of RegTech in Medical Devices & SaMD: 8…
Emerging technologies like artificial intelligence, predictive analytics, and blockchain are redefining how medical devices and Software as …
Read more
Major U.S. Reform Bill Triggers Regulatory Consequences…
July 4, 2025 – In a move set to reshape key sectors, U.S. President Donald Trump has signed into law H.R.1 – the “One Big Beautiful Bi…
Read more
EMA Releases June 2025 PRAC Safety Updates for EU-Autho…
The European Medicines Agency (EMA) has released updated safety signal recommendations from its PRAC committee on June 2, 2025.This update r…
Read more
FDA Launches “Elsa”: Agency-Wide Generative…
On June 2, 2025, the U.S. Food and Drug Administration (FDA) officially launched Elsa, a generative artificial intelligence (AI) tool develo…
Read more
MAHA Commission Releases Report on U.S. Childhood Chron…
Presidential Commission Releases Landmark Report on U.S. Childhood Chronic Disease Crisis May 22, 2025 – The Presidential Commission to Ma…
Read more